Bussiness5 months ago
GeoVax Reports Second Quarter 2024 Financial Results and Provides Business Update
GeoVax, Inc. Awarded BARDA Project NextGen (PNG) contract to advance GeoVax’s multi-antigen vaccine candidate, GEO-CM04S1, into 10,000-participant randomized, comparative Phase 2b COVID-19 vaccine study BARDA PNG...
